• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[遗传性血色素沉着症的诊断与治疗]

[Diagnosis and treatment of genetic haemochromatosis].

作者信息

Milman Nils Thorm

机构信息

Rheumatologisk Klinik TA, Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark.

出版信息

Ugeskr Laeger. 2013 Apr 15;175(16):1109-12.

PMID:23651749
Abstract

Genetic haemochromatosis is a complex disorder/disease, which can be caused by a multiplicity of mutations in genes involved in iron metabolism being located on different chromosomes. In Caucasians, mutations in the HFE-gene account for the most common form of haemochromatosis (type 1). Non-HFE-haemochromatoses are less frequent and consist of juvenile haemochromatosis (type 2A and 2B) and TRF2-related haemochromatosis (type 3), which all respond to phlebotomies. The others comprise ferroportin disease (type 4A) atypical ferroportin disease (type 4B), acoeruloplasminaemia, atransferrinaemia and DMT1-associated haemochromatosis.

摘要

遗传性血色素沉着症是一种复杂的病症,它可能由位于不同染色体上的参与铁代谢的基因发生多种突变引起。在白种人中,HFE基因的突变导致了血色素沉着症最常见的形式(1型)。非HFE型血色素沉着症较为少见,包括青少年血色素沉着症(2A型和2B型)以及与转铁蛋白2(TRF2)相关的血色素沉着症(3型),这些类型对放血疗法均有反应。其他类型包括铁转运蛋白病(4A型)、非典型铁转运蛋白病(4B型)、无血浆铜蓝蛋白血症、无转铁蛋白血症以及与二价金属离子转运体1(DMT1)相关的血色素沉着症。

相似文献

1
[Diagnosis and treatment of genetic haemochromatosis].[遗传性血色素沉着症的诊断与治疗]
Ugeskr Laeger. 2013 Apr 15;175(16):1109-12.
2
Current approach to hemochromatosis.血色素沉着症的当前治疗方法。
Blood Rev. 2008 Jul;22(4):195-210. doi: 10.1016/j.blre.2008.03.001. Epub 2008 Apr 21.
3
Genetic haemochromatosis: genes and mutations associated with iron loading.遗传性血色素沉着症:与铁负荷相关的基因和突变
Best Pract Res Clin Haematol. 2002 Jun;15(2):261-76. doi: 10.1016/s1521-6926(02)90207-0.
4
HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.印度原发性血色素沉着症患者不存在HFE、铁调素和铁转运蛋白基因突变。
Natl Med J India. 2006 Jan-Feb;19(1):20-3.
5
Recent advances in understanding haemochromatosis: a transition state.铁过载疾病认识的最新进展:一种过渡状态
J Med Genet. 2004 Oct;41(10):721-30. doi: 10.1136/jmg.2004.020644.
6
Review article: the genetic basis of haemochromatosis.综述文章:血色素沉着症的遗传基础。
Aliment Pharmacol Ther. 2007 Aug 1;26(3):331-42. doi: 10.1111/j.1365-2036.2007.03387.x.
7
Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.在HFE型血色素沉着症中,主要致病机制是铁调素释放缺陷而非合成缺陷。
Med Hypotheses. 2008;70(6):1197-200. doi: 10.1016/j.mehy.2007.10.007. Epub 2007 Dec 3.
8
Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.HAMP和HFE基因突变的双基因遗传导致不同类型的血色素沉着症。
Hum Mol Genet. 2003 Sep 1;12(17):2241-7. doi: 10.1093/hmg/ddg225. Epub 2003 Jul 15.
9
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.通过对非HFE遗传性血色素沉着症的研究获得对铁稳态的新认识。
Best Pract Res Clin Haematol. 2005 Jun;18(2):235-50. doi: 10.1016/j.beha.2004.09.004.
10
Inherited iron loading: genetic testing in diagnosis and management.遗传性铁过载:诊断与管理中的基因检测
Blood Rev. 2005 Mar;19(2):69-88. doi: 10.1016/j.blre.2004.03.003.

引用本文的文献

1
A Review of Nutrients and Compounds, Which Promote or Inhibit Intestinal Iron Absorption: Making a Platform for Dietary Measures That Can Reduce Iron Uptake in Patients with Genetic Haemochromatosis.促进或抑制肠道铁吸收的营养素和化合物综述:为遗传性血色素沉着症患者降低铁摄取的饮食措施搭建平台。
J Nutr Metab. 2020 Sep 14;2020:7373498. doi: 10.1155/2020/7373498. eCollection 2020.
2
Diagnosis and Treatment of Genetic -Hemochromatosis: The Danish Aspect.遗传性血色素沉着症的诊断与治疗:丹麦视角
Gastroenterology Res. 2019 Oct;12(5):221-232. doi: 10.14740/gr1206. Epub 2019 Oct 4.